261 related articles for article (PubMed ID: 10407495)
1. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of low density lipoprotein oxidation by thyronines and probucol.
Hanna AN; Feller DR; Witiak DT; Newman HA
Biochem Pharmacol; 1993 Feb; 45(3):753-62. PubMed ID: 8442772
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits.
Mao SJ; Yates MT; Rechtin AE; Jackson RL; Van Sickle WA
J Med Chem; 1991 Jan; 34(1):298-302. PubMed ID: 1992130
[TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia.
Dujovne CA; Harris WS; Gerrond LL; Fan J; Muzio F
Am J Cardiol; 1994 Jul; 74(1):38-42. PubMed ID: 8017303
[TBL] [Abstract][Full Text] [Related]
5. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.
Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA
Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765
[TBL] [Abstract][Full Text] [Related]
6. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
Andersen HO; Holm P; Nordestgaard BG; Hansen BF; Kjeldsen K; Elinder LS; Stender S
J Mol Cell Cardiol; 1995 Aug; 27(8):1561-71. PubMed ID: 8523419
[TBL] [Abstract][Full Text] [Related]
7. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways.
Negre-Salvayre A; Alomar Y; Troly M; Salvayre R
Biochim Biophys Acta; 1991 Jun; 1096(4):291-300. PubMed ID: 2065102
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Kleinveld HA; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202
[TBL] [Abstract][Full Text] [Related]
9. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
Lauridsen ST; Mortensen A
Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of atherosclerosis in a modified strain of hypercholesterolemic Watanabe rabbits with use of a probucol analogue (MDL 29,311) that does not lower serum cholesterol.
Mao SJ; Yates MT; Parker RA; Chi EM; Jackson RL
Arterioscler Thromb; 1991; 11(5):1266-75. PubMed ID: 1911712
[TBL] [Abstract][Full Text] [Related]
11. S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
Breugnot C; Privat S; Guillonneau C; Regnier G; Bouzom F; Vilaine JP; Lenaers A
J Pharmacol Exp Ther; 1994 May; 269(2):515-20. PubMed ID: 8182520
[TBL] [Abstract][Full Text] [Related]
12. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.
Barnhart RL; Busch SJ; Jackson RL
J Lipid Res; 1989 Nov; 30(11):1703-10. PubMed ID: 2614272
[TBL] [Abstract][Full Text] [Related]
13. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
[TBL] [Abstract][Full Text] [Related]
14. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716
[TBL] [Abstract][Full Text] [Related]
16. The in vitro and ex vivo antioxidant properties, hypolipidaemic and antiatherosclerotic activities of water extract of Moringa oleifera Lam. leaves.
Chumark P; Khunawat P; Sanvarinda Y; Phornchirasilp S; Morales NP; Phivthong-Ngam L; Ratanachamnong P; Srisawat S; Pongrapeeporn KU
J Ethnopharmacol; 2008 Mar; 116(3):439-46. PubMed ID: 18249514
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies.
Aviram M; Dankner G; Cogan U; Hochgraf E; Brook JG
Metabolism; 1992 Mar; 41(3):229-35. PubMed ID: 1542259
[TBL] [Abstract][Full Text] [Related]
18. Gemfibrozil metabolite inhibits in vitro low-density lipoprotein (LDL) oxidation and diminishes cytotoxicity induced by oxidized LDL.
Kawamura M; Miyazaki S; Teramoto T; Ashidate K; Thoda H; Ando N; Kaneko K
Metabolism; 2000 Apr; 49(4):479-85. PubMed ID: 10778872
[TBL] [Abstract][Full Text] [Related]
19. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants.
Fruebis J; Bird DA; Pattison J; Palinski W
J Lipid Res; 1997 Dec; 38(12):2455-64. PubMed ID: 9458269
[TBL] [Abstract][Full Text] [Related]
20. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation.
Keaney JF; Xu A; Cunningham D; Jackson T; Frei B; Vita JA
J Clin Invest; 1995 Jun; 95(6):2520-9. PubMed ID: 7769097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
